Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 22266 | 388 | 30.5 | 57% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
| 1 | 3 | CHEMISTRY, ORGANIC//TETRAHEDRON LETTERS//JOURNAL OF ORGANIC CHEMISTRY | 237069 |
| 830 | 2 | IMINOSUGARS//AZASUGARS//GLYCOSIDASE INHIBITORS | 11836 |
| 22266 | 1 | HOMOHARRINGTONINE//CEPHALOTAXINE//OMACETAXINE MEPESUCCINATE | 388 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | HOMOHARRINGTONINE | authKW | 2720080 | 15% | 61% | 57 |
| 2 | CEPHALOTAXINE | authKW | 1716128 | 7% | 84% | 26 |
| 3 | OMACETAXINE MEPESUCCINATE | authKW | 515107 | 3% | 55% | 12 |
| 4 | CEPHALOTAXUS KOREANA | authKW | 393493 | 1% | 100% | 5 |
| 5 | CEPHALOTAXUS GRIFFITHII | authKW | 327909 | 1% | 83% | 5 |
| 6 | CEPHALOTAXUS SINENSIS | authKW | 327909 | 1% | 83% | 5 |
| 7 | HAINANOLIDE | authKW | 314794 | 1% | 100% | 4 |
| 8 | HOMOHARRINGTONINE HHT | authKW | 314794 | 1% | 100% | 4 |
| 9 | CEPHALOTAXUS LANCEOLATA | authKW | 236096 | 1% | 100% | 3 |
| 10 | HARRINGTONOLIDE | authKW | 236096 | 1% | 100% | 3 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Chemistry, Organic | 1427 | 28% | 0% | 109 |
| 2 | Oncology | 746 | 24% | 0% | 93 |
| 3 | Hematology | 289 | 9% | 0% | 35 |
| 4 | Chemistry, Multidisciplinary | 244 | 19% | 0% | 72 |
| 5 | Chemistry, Medicinal | 204 | 7% | 0% | 29 |
| 6 | Pharmacology & Pharmacy | 184 | 15% | 0% | 58 |
| 7 | Integrative & Complementary Medicine | 97 | 2% | 0% | 8 |
| 8 | Plant Sciences | 33 | 6% | 0% | 22 |
| 9 | Medical Laboratory Technology | 15 | 1% | 0% | 5 |
| 10 | Medicine, General & Internal | 4 | 3% | 0% | 13 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | NONCLIN DMPK | 141655 | 1% | 60% | 3 |
| 2 | ARNOLD BECKMAN S CHEM SYNTH | 78699 | 0% | 100% | 1 |
| 3 | BIOTECHNOL MED PLANT IMPROVEMENT | 78699 | 0% | 100% | 1 |
| 4 | CIC9504 INVEST CLIN | 78699 | 0% | 100% | 1 |
| 5 | ELEEMENTOORGAN CHEM | 78699 | 0% | 100% | 1 |
| 6 | FIRST HOSP HUAIAN | 78699 | 0% | 100% | 1 |
| 7 | HANGZHOU HEMATOL | 78699 | 0% | 100% | 1 |
| 8 | HEMATOL COMBINED MULTIORGAN TRANSPLA | 78699 | 0% | 100% | 1 |
| 9 | ICNUMRUNS 7272 | 78699 | 0% | 100% | 1 |
| 10 | LANGFANG CHINESE MED HOSP | 78699 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INTERNATIONAL JOURNAL OF PHARMACOGNOSY | 3304 | 1% | 1% | 3 |
| 2 | CANCER TREATMENT REPORTS | 1739 | 2% | 0% | 7 |
| 3 | CHINESE CHEMICAL LETTERS | 1132 | 3% | 0% | 11 |
| 4 | INVESTIGATIONAL NEW DRUGS | 763 | 1% | 0% | 5 |
| 5 | JOURNAL OF ORGANIC CHEMISTRY | 651 | 5% | 0% | 21 |
| 6 | EUROPEAN JOURNAL OF ORGANIC CHEMISTRY | 622 | 3% | 0% | 10 |
| 7 | LEUKEMIA | 500 | 2% | 0% | 7 |
| 8 | TETRAHEDRON LETTERS | 491 | 6% | 0% | 22 |
| 9 | JOURNAL OF HEMATOLOGY & ONCOLOGY | 463 | 1% | 0% | 2 |
| 10 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 410 | 1% | 0% | 2 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HOMOHARRINGTONINE | 2720080 | 15% | 61% | 57 | Search HOMOHARRINGTONINE | Search HOMOHARRINGTONINE |
| 2 | CEPHALOTAXINE | 1716128 | 7% | 84% | 26 | Search CEPHALOTAXINE | Search CEPHALOTAXINE |
| 3 | OMACETAXINE MEPESUCCINATE | 515107 | 3% | 55% | 12 | Search OMACETAXINE+MEPESUCCINATE | Search OMACETAXINE+MEPESUCCINATE |
| 4 | CEPHALOTAXUS KOREANA | 393493 | 1% | 100% | 5 | Search CEPHALOTAXUS+KOREANA | Search CEPHALOTAXUS+KOREANA |
| 5 | CEPHALOTAXUS GRIFFITHII | 327909 | 1% | 83% | 5 | Search CEPHALOTAXUS+GRIFFITHII | Search CEPHALOTAXUS+GRIFFITHII |
| 6 | CEPHALOTAXUS SINENSIS | 327909 | 1% | 83% | 5 | Search CEPHALOTAXUS+SINENSIS | Search CEPHALOTAXUS+SINENSIS |
| 7 | HAINANOLIDE | 314794 | 1% | 100% | 4 | Search HAINANOLIDE | Search HAINANOLIDE |
| 8 | HOMOHARRINGTONINE HHT | 314794 | 1% | 100% | 4 | Search HOMOHARRINGTONINE+HHT | Search HOMOHARRINGTONINE+HHT |
| 9 | CEPHALOTAXUS LANCEOLATA | 236096 | 1% | 100% | 3 | Search CEPHALOTAXUS+LANCEOLATA | Search CEPHALOTAXUS+LANCEOLATA |
| 10 | HARRINGTONOLIDE | 236096 | 1% | 100% | 3 | Search HARRINGTONOLIDE | Search HARRINGTONOLIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | ABDELKAFI, H , NAY, B , (2012) NATURAL PRODUCTS FROM CEPHALOTAXUS SP.: CHEMICAL DIVERSITY AND SYNTHETIC ASPECTS.NATURAL PRODUCT REPORTS. VOL. 29. ISSUE 8. P. 845 -869 | 108 | 73% | 36 |
| 2 | KANTARJIAN, HM , TALPAZ, M , SANTINI, V , MURGO, A , CHESON, B , O'BRIEN, SM , (2001) HOMOHARRINGTONINE - HISTORY, CURRENT RESEARCH, AND FUTURE DIRECTIONS.CANCER. VOL. 92. ISSUE 6. P. 1591-1605 | 42 | 82% | 97 |
| 3 | BERHAL, F , PERARD-VIRET, J , ROYER, J , (2010) STEREOSELECTIVE SYNTHESIS OF ENANTIOPURE ANALOGUES OF (-)-CEPHALOTAXINE.TETRAHEDRON-ASYMMETRY. VOL. 21. ISSUE 3. P. 325 -332 | 31 | 89% | 4 |
| 4 | EL BIALY, SA , ABDEL-WAHAB, BF , (2013) SYNTHETIC STRATEGIES TO BENZOPYRROLO[1,2-A]AZEPINES.TETRAHEDRON. VOL. 69. ISSUE 45. P. 9357 -9371 | 34 | 60% | 2 |
| 5 | KANTARJIAN, HM , O'BRIEN, S , CORTES, J , (2013) HOMOHARRINGTONINE/OMACETAXINE MEPESUCCINATE: THE LONG AND WINDING ROAD TO FOOD AND DRUG ADMINISTRATION APPROVAL.CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. VOL. 13. ISSUE 5. P. 530-533 | 20 | 87% | 18 |
| 6 | NOVOTNY, L , AL-TANNAK, NF , HUNAKOVA, L , (2016) PROTEIN SYNTHESIS INHIBITORS OF NATURAL ORIGIN FOR CML THERAPY: SEMISYNTHETIC HOMOHARRINGTONINE (OMACETAXINE MEPESUCCINATE).NEOPLASMA. VOL. 63. ISSUE 4. P. 495 -503 | 28 | 64% | 0 |
| 7 | MARGUERIT, M , LITTLE, G , WANG, Y , HE, LL , ALLWEIN, S , REIF, J , ROSSI, J , ROEMMELE, R , BAKALE, R , (2015) TOTAL SYNTHESIS OF [C-14]-LABELLED HOMOHARRINGTONINE.EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. VOL. . ISSUE 36. P. 8003 -8010 | 20 | 83% | 1 |
| 8 | ESMIEU, WR , WORDEN, SM , CATTERICK, D , WILSON, C , HAYES, CJ , (2008) A FORMAL SYNTHESIS OF (-)-CEPHALOTAXINE.ORGANIC LETTERS. VOL. 10. ISSUE 14. P. 3045 -3048 | 25 | 69% | 20 |
| 9 | QUINTAS-CARDAMA, A , KANTARJIAN, H , CORTES, J , (2009) HOMOHARRINGTONINE, OMACETAXINE MEPESUCCINATE, AND CHRONIC MYELOID LEUKEMIA CIRCA 2009.CANCER. VOL. 115. ISSUE 23. P. 5382-5393 | 29 | 55% | 44 |
| 10 | ZHANG, HJ , HU, L , MA, ZQ , LI, RN , ZHANG, Z , TAO, C , CHENG, B , LI, Y , WANG, HF , ZHAI, HB , (2016) TOTAL SYNTHESIS OF THE DITERPENOID (+)-HARRINGTONOLIDE.ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 55. ISSUE 38. P. 11638 -11641 | 22 | 67% | 0 |
Classes with closest relation at Level 1 |